Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia
Clinical trial NCT01944943 · TERMINATED
Trial details
- NCT number
- NCT01944943
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2014-08-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.